FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W6179093> ?p ?o ?g. }

• W6179093 endingPage "1274" @default.
• W6179093 startingPage "1262" @default.
• W6179093 abstract "Ovarian cancer is the number one cause of death from gynecologic malignancy. A defective p53 pathway is a hallmark of ovarian carcinoma. The p53 mutation correlates significantly with resistance to platinum-based chemotherapy, early relapse and shortened overall survival in ovarian cancer patients. PUMA (p53 upregulated modulator of apoptosis), a BH3-only Bcl-2 family protein, was recently identified as a transcriptional target of p53 and a potent apoptosis inducer in various cancer cells. In this study, we showed that the induction of PUMA by cisplatin was abolished in p53-deficient SKOV3 cells. Elevated expression of PUMA-induced apoptosis and sensitized A2780s and SKOV3 ovarian cancer cells to cisplatin, and the combination of PUMA and low-dose cisplatin, significantly suppressed xenograft tumor growth in vivo through enhanced induction of apoptosis compared with treatment with PUMA or cisplatin alone. The effects of PUMA were mediated by enhanced caspase activation and release of cytochrome c and Smac (second mitochondria-derived activator of caspase) into the cytosol. Furthermore, PUMA chemosensitized intrinsically resistant SKOV3 cells to cisplatin through downregulation of B-cell lymphoma-extra large (Bcl-xL) and myeloid cell leukemia sequence 1 (Mcl-1). PUMA-mediated Bcl-xL downregulation mainly happened at the transcription level, whereas PUMA-induced Mcl-1 downregulation was associated with caspase-dependent cleavage and proteasome-mediated degradation. To our knowledge, these data suggest a new mechanism by which overexpression of PUMA enhances sensitivity of SKOV3 cells to cisplatin by lowering the threshold set simultaneously by Bcl-xL and Mcl-1. Taken together, our findings indicate that PUMA is an important modulator of therapeutic responses of ovarian cancer cells and is potentially useful as a chemosensitizer in ovarian cancer therapy." @default.
• W6179093 created "2016-06-24" @default.
• W6179093 creator A5007016148 @default.
• W6179093 creator A5010235801 @default.
• W6179093 creator A5020147975 @default.
• W6179093 creator A5026620854 @default.
• W6179093 creator A5035528148 @default.
• W6179093 creator A5053691210 @default.
• W6179093 creator A5065098852 @default.
• W6179093 creator A5068950959 @default.
• W6179093 creator A5076031419 @default.
• W6179093 creator A5078257641 @default.
• W6179093 creator A5090403310 @default.
• W6179093 date "2011-08-19" @default.
• W6179093 modified "2023-10-15" @default.
• W6179093 title "The p53 Upregulated Modulator of Apoptosis (PUMA) Chemosensitizes Intrinsically Resistant Ovarian Cancer Cells to Cisplatin by Lowering the Threshold Set by Bcl-xL and Mcl-1" @default.
• W6179093 cites W1601414978 @default.
• W6179093 cites W1604468403 @default.
• W6179093 cites W1650797637 @default.
• W6179093 cites W1741860215 @default.
• W6179093 cites W1963528972 @default.
• W6179093 cites W1963592300 @default.
• W6179093 cites W1967142704 @default.
• W6179093 cites W1978259246 @default.
• W6179093 cites W1983438616 @default.
• W6179093 cites W1984382819 @default.
• W6179093 cites W1985327599 @default.
• W6179093 cites W1991454815 @default.
• W6179093 cites W1992396964 @default.
• W6179093 cites W1993079965 @default.
• W6179093 cites W1997788846 @default.
• W6179093 cites W1999103741 @default.
• W6179093 cites W2000080731 @default.
• W6179093 cites W2000686057 @default.
• W6179093 cites W2004860729 @default.
• W6179093 cites W2006193439 @default.
• W6179093 cites W2009458932 @default.
• W6179093 cites W2009486785 @default.
• W6179093 cites W2016982251 @default.
• W6179093 cites W2022467034 @default.
• W6179093 cites W2032603938 @default.
• W6179093 cites W2034269086 @default.
• W6179093 cites W2038599271 @default.
• W6179093 cites W2042850275 @default.
• W6179093 cites W2044842510 @default.
• W6179093 cites W2050685956 @default.
• W6179093 cites W2068025977 @default.
• W6179093 cites W2073308580 @default.
• W6179093 cites W2081445507 @default.
• W6179093 cites W2085301972 @default.
• W6179093 cites W2092949189 @default.
• W6179093 cites W2099113454 @default.
• W6179093 cites W2099635275 @default.
• W6179093 cites W2102597691 @default.
• W6179093 cites W2106771830 @default.
• W6179093 cites W2107277218 @default.
• W6179093 cites W2111871531 @default.
• W6179093 cites W2112968535 @default.
• W6179093 cites W2115567169 @default.
• W6179093 cites W2119683782 @default.
• W6179093 cites W2122855165 @default.
• W6179093 cites W2129361942 @default.
• W6179093 cites W2133459528 @default.
• W6179093 cites W2142168740 @default.
• W6179093 cites W2144022011 @default.
• W6179093 cites W2148220182 @default.
• W6179093 cites W2150822910 @default.
• W6179093 cites W2152876030 @default.
• W6179093 cites W2154898787 @default.
• W6179093 cites W2187668060 @default.
• W6179093 cites W2400576640 @default.
• W6179093 cites W38481886 @default.
• W6179093 cites W4293241248 @default.
• W6179093 doi "https://doi.org/10.2119/molmed.2011.00176" @default.
• W6179093 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3321807" @default.
• W6179093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21863213" @default.
• W6179093 hasPublicationYear "2011" @default.
• W6179093 type Work @default.
• W6179093 sameAs 6179093 @default.
• W6179093 citedByCount "42" @default.
• W6179093 countsByYear W61790932012 @default.
• W6179093 countsByYear W61790932013 @default.
• W6179093 countsByYear W61790932014 @default.
• W6179093 countsByYear W61790932015 @default.
• W6179093 countsByYear W61790932016 @default.
• W6179093 countsByYear W61790932017 @default.
• W6179093 countsByYear W61790932018 @default.
• W6179093 countsByYear W61790932019 @default.
• W6179093 countsByYear W61790932020 @default.
• W6179093 countsByYear W61790932021 @default.
• W6179093 countsByYear W61790932022 @default.
• W6179093 countsByYear W61790932023 @default.
• W6179093 crossrefType "journal-article" @default.
• W6179093 hasAuthorship W6179093A5007016148 @default.
• W6179093 hasAuthorship W6179093A5010235801 @default.
• W6179093 hasAuthorship W6179093A5020147975 @default.
• W6179093 hasAuthorship W6179093A5026620854 @default.
• W6179093 hasAuthorship W6179093A5035528148 @default.

• next